Mentions
Extended reach
Total likes
Video views
AI synopsis
The discussed posts mainly promote reading the review article, often quoting or referencing the publication's findings, indicating positive reception and interest. The tone is professional and informative, emphasizing the significance of Pegaspargase in treating acute lymphoblastic leukemia and its advantages over other forms, which reflects a moderate level of engagement and perceived impact within the medical community.
Most discussions recognize the value of Pegaspargase, with several explicitly referencing its benefits for treating ALL, indicating general support for the publication’s conclusions.
Participants show moderate curiosity, as many posts highlight the publication and provide brief endorsements, reflecting some engagement but not deep analysis.
Posts include mentions of specific research articles, such as the review by Heo YA et al., showing an active interest in the topic and its relevance to current treatment options.
Some comments and references suggest that the publication is expected to influence ongoing research and clinical practice, especially because it discusses treatment improvements.
Want to learn more about Pegaspargase? Read our recently published #openaccess Adis Drug Evaluation on the drug in its treatment of Acute Lymphoblastic Leukaemia https://t.co/b80WpVCskl #ALL #ESMO19 https://t.co/a1hKaphT3C
Pegaspargase: A Review in Acute Lymphoblastic Leukaemia. https://t.co/j7QIvQVYhF
RT @GEFP_SEFH: Pegaspargase: A Review in Acute Lymphoblastic Leukaemia. https://t.co/j7QIvQVYhF
RT @AdisJournals: Want to learn more about Pegaspargase? Read our recently published #openaccess Adis Drug Evaluation on the drug in its t…
[trend] up+1: *Heo YA* et al (Drugs) **Pegaspargase: A Review in Acute Lymphoblastic Leukaemia.** https://t.co/OY0tJgsJyG
[trend] up+1: *Heo YA* et al (Drugs) **Pegaspargase: A Review in Acute Lymphoblastic Leukaemia.** https://t.co/OY0tJgKkqe
Pegaspargase is a modified enzyme used to treat ALL, offering longer-lasting effects and less frequent dosing. It’s effective in patients with hypersensitivity to traditional enzymes, with a tolerable safety profile…
RT @AdisJournals: Want to learn more about Pegaspargase? Read our recently published #openaccess Adis Drug Evaluation on the drug in its t…
Want to learn more about Pegaspargase? Read our recently published #openaccess Adis Drug Evaluation on the drug in its treatment of Acute Lymphoblastic Leukaemia https://t.co/b80WpVCskl #ALL #ESMO19 https://t.co/a1hKaphT3C
[trend] up+1: *Heo YA* et al (Drugs) **Pegaspargase: A Review in Acute Lymphoblastic Leukaemia.** https://t.co/OY0tJgsJyG
[trend] up+1: *Heo YA* et al (Drugs) **Pegaspargase: A Review in Acute Lymphoblastic Leukaemia.** https://t.co/OY0tJgKkqe
[trend] up+1: *Heo YA* et al (Drugs) **Pegaspargase: A Review in Acute Lymphoblastic Leukaemia.** https://t.co/OY0tJgsJyG
[trend] up+4: *Heo YA* et al (Drugs) **Pegaspargase: A Review in Acute Lymphoblastic Leukaemia.** https://t.co/OY0tJgsJyG
[trend] up+1: *Heo YA* et al (Drugs) **Pegaspargase: A Review in Acute Lymphoblastic Leukaemia.** https://t.co/OY0tJgsJyG
[trend] up+1: *Heo YA* et al (Drugs) **Pegaspargase: A Review in Acute Lymphoblastic Leukaemia.** https://t.co/OY0tJgsJyG
RT @GEFP_SEFH: Pegaspargase: A Review in Acute Lymphoblastic Leukaemia. https://t.co/j7QIvQVYhF
Pegaspargase: A Review in Acute Lymphoblastic Leukaemia. https://t.co/j7QIvQVYhF
[trend] new: *Heo YA* et al (Drugs) **Pegaspargase: A Review in Acute Lymphoblastic Leukaemia.** https://t.co/OY0tJgsJyG